After China Balloon Incident, House Financial Services Talks Risks To US
What are the risks China poses to the U.S. industrial supply chain and what can be done about it? Some quotes from Congress and witnesses from a Feb. 7 hearing.
State Department Official Says U.S. Needs Domestic Investments in Supply Chains to Compete with China
Notes from the recent Senate Foreign Relations Committee hearing on China. What the No. 2 at State said about China and U.S. supply chain risk.
Three Senators Send Letter to China Online Retailer SHEIN: Are You Using Banned Cotton?
A bipartisan trio of Senators sent a letter to China retailer SHEIN asking for assurances their clothes sold here are not made with banned cotton. They also inquire about the de minimis loophole that makes SHEIN possible.
Trade Deals Need to Reconsider Supply Chain Risks – GAO Report
A new report by the Government Accountability Office highlights the need for revamped trade deals. But missing from the discussion is the case for more local supply chains.
U.S. Beats Trade Deficit Record, Ends 2022 With $1.19 Trillion Goods Gap
The latest trade figures show historic deficits with Mexico, Canada and Vietnam. Meanwhile, the 2022 deficit with China and the EU is the second largest of all time.
Is the U.S. Still Financing China’s Military Might?
Yes, in many ways the U.S. is funding China’s defense sector through venture capital, portfolio investments, and computer hardware sales to companies on the Entity List.
CPA Trade Counsel Promotes Tariffs With Capitol Hill Staff
On January 31, CPA trade counsel Charles Benoit gives a masters class on the history of trade tariffs, and how they were used to build the U.S. economy.
Pharmaceuticals Are Heavily Outsourced. Can the U.S. Make More of it Here?
The U.S. is increasingly dependent on imports for drugs. One reason: a tax avoidance scheme that pits U.S. manufacturing up against Europe. What can be done about this problem?
European Pharma Considers Reshoring from India, China. Where’s the US?
The Covid-19 pandemic gave big pharma big payday. But it also caused the industry to rethink a globalized supply chain centered on Asia. What will it take to reshore at least some generic drugs to the U.S.
Supply Chain Dependence Makes Reshoring Harder – McKinsey
Can the U.S. really bring manufacturing home? A McKinsey study shows that existing concentration of some supply chains will make it hard. Here’s what needs to be done.
